Gunn et al. Luchetti, S., Huitinga, I., and Swaab, D. F. (2011). Neurosteroid and GABA- A receptor alterations in Alzheimer’s disease, Parkinson’s disease and mul- tiple sclerosis. Neuroscience 191, 6–21. Ludwig, M., and Leng, G. (2006). Den- dritic peptide release and peptide- dependent behaviours. Nat. Rev. Neurosci. 7, 126–136. Lupien, S. J., McEwen, B. S., Gunnar, M. R., and Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 10, 434–445. Magarinos, A. M., and McEwen, B. S. (1995). Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glu- cocorticoid secretion and excitatory amino acid receptors. Neuroscience 69, 89–98. Maguire, J., and Mody, I. (2007). Neu- rosteroid synthesis-mediated regula- tion of GABAA receptors: relevance to the ovarian cycle and stress. J. Neurosci. 27, 2155–2162. Maguire, J., and Mody, I. (2008). GABAAR plasticity during preg- nancy: relevance to postpartum depression. Neuron 59, 207–213. Maguire, J., and Mody, I. (2009). Steroid hormone ﬂuctuations and GABAAR plasticity. Psychoneuroendocrinology 34(Suppl. 1), S84–S90. Makino, S., Gold, P. W., and Schulkin, J. (1994). Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellu- lar region of the paraventricular nucleus of the hypothalamus. Brain Res. 640, 105–112. Matsumoto, K., Uzunova, V., Pinna, G., Taki, K., Uzunov, D. P., Watan- abe, H., Mienville, J. M., Guidotti, A., and Costa, E. (1999). Per- missive role of brain allopreg- nanolone content in the regulation of pentobarbital-induced righting reﬂex loss. Neuropharmacology 38, 955–963. McEwen, B. S. (2003). Early life inﬂu- ences on life-long patterns of behav- iour and health. Ment. Retard Dev. Disabil. Res. Rev. 9, 149–154. McEwen, B. S. (2010). Stress, sex, and neural adaptation to a changing environment: mechanisms of neu- ronal remodeling. Ann. N. Y. Acad. Sci. 1204(Suppl.), E38–E59. McGowan, P. O., Sasaki, A., D’Alessio, A. C., Dymov, S., Labonte, B., Szyf, M., Turecki, G., and Meaney, M. J. (2009). Epigenetic regula- tion of the glucocorticoid recep- tor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342–348. www.frontiersin.org Meaney, M. J., Viau, V., Bhatnagar, S., Betito, K., Iny, L. J., O’Donnell, D., and Mitchell, J. B. (1991). Cellular mechanisms underlying the devel- opment and expression of individ- ual differences in the hypothalamic- pituitary-adrenal stress response. J. Steroid Biochem. Mol. Biol. 39, 265–274. Melcangi, R. C., Celotti, F., Castano, P., and Martini, L. (1993). Differen- tial localisation of the 5α-reductase and the 3α-hydroxysteroid dehy- drogenase in neuronal and glial cell cultures. Endocrinology 132, 1252–1259. Mellon, S. H. (2004). “Synthesis, enzymes localizations and regula- tion of neurosteroids,” in Neuros- teroid Effects in the Central Nervous System: The Role of the GABAAR. Methods and New Frontiers in Neuro- science, ed. S. S. Smith (Boca Raton: CRC Press), 1–46. Mellon, S. H., and Grifﬁn, L. D. (2002). Neurosteroids: biochemistry and clinical signiﬁcance. Trends Endocrinol. Metab. 13, 35–43. Mellon, S. H., and Vaudry, H. (2001). Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46, 33–78. Mennerick, S., He, Y., Jiang, X., Man- ion, B. D., Wang, M., Shute, A., Benz, A., Evers, A. S., Covey, D. F., and Zorumski, C. F. (2004). Selective antagonism of 5α-reduced neuros- teroid effects at GABAA receptors. Mol. Pharmacol. 65, 1191–1197. Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z. P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S. G., Sage, J. R., Fanselow, M. S., Guidotti, A., Spigelman, I., Li, Z., DeLorey, T. M., Olsen, R. W., and Homan- ics, G. E. (1999). Attenuated sensi- tivity to neuroactive steroids in γ- aminobutyrate type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96, 12905–12910. Miklos, I. H., and Kovacs, K. J. (2002). GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy. Neuroscience 113, 581–592. Mitev, Y. A., Darwish, M., Wolf, S. S., Holsboer, F., Almeida, O. F., and Patchev, V. K. (2003). Gen- der differences in the regulation of 3α-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress pro- tection. Neuroscience 120, 541–549. Mitra, R., and Sapolsky, R. M. (2008). Acute corticosterone treatment is GABAA receptors, neurosteroids, and stress sufﬁcient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 105, 5573–5578. Molina-Hernandez, M., Tellez- Alcantara, N. P., Garcia, J. P., Lopez, J. I., and Jaramillo, M. T. (2005). Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats. Pharmacol. Biochem. Behav. 80, 401–409. Morrow, A. L., Porcu, P., Boyd, K. N., and Grant, K. A. (2006). Hypothalamic- pituitary-adrenal axis modulation of GABAergic neuroactive steroids inﬂuences ethanol sensitivity and drinking behavior. Dialogues Clin. Neurosci. 8, 463–477. Morrow, A. L., VanDoren, M. J., Pen- land, S. N., and Matthews, D. B. (2001). The role of GABAergic neu- roactive steroids in ethanol action, tolerance and dependence. Brain Res. Brain Res. Rev. 37, 98–109. Motzo, C., Porceddu, M. L., Maira, G., Flore, G., Concas, A., Dazzi, L., and Biggio, G. (1996). Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely mov- ing rats by the neurosteroid allo- pregnanolone. J. Psychopharmacol. 10, 266–272. Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmuhl, Y., Fis- cher, D., Holsboer, F., Wotjak, C. T., Almeida, O. F., and Spengler, D. (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci. 12, 1559–1566. Neigh, G. N., Gillespie, C. F., and Nemeroff, C. B. (2009). The neu- robiological toll of child abuse and neglect. Trauma Violence Abuse 10, 389–410. Nguyen, P. N., Billiards, S. S., Walker, D. W., and Hirst, J. J. (2003). Changes in 5α-pregnane steroids and neu- rosteroidogenic enzyme expression in fetal sheep with umbilicoplacen- tal embolization. Pediatr. Res. 54, 840–847. Nguyen, P. N., Yan, E. B., Castillo- Melendez, M., Walker, D. W., and Hirst, J. J. (2004). Increased allo- pregnanolone levels in the fetal sheep brain following umbilical cord occlusion. J. Physiol. (Lond.) 560, 593–602. Nie, Z., Schweitzer, P., Roberts, A. J., Madamba, S. G., Moore, S. D., and Siggins, G. R. (2004). Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303, 1512–1514. Nusser, Z., Sieghart, W., and Somogyi, P. (1998). Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cere- bellar granule cells. J. Neurosci. 18, 1693–1703. Olsen, R. W., and Sieghart, W. (2008). International Union of Phar- macology. LXX. Subtypes of γ- aminobutyric acidA receptors: clas- siﬁcation on the basis of sub- unit composition, pharmacology, and function. Update. Pharmacol. Rev. 60, 243–260. Olsen, R. W., and Sieghart, W. (2009). GABAA receptors: subtypes pro- vide diversity of function and phar- macology. Neuropharmacology 56, 141–148. Orchinik, M., Weiland, N. G., and McEwen, B. S. (1995). Chronic expo- sure to stress levels of corticos- terone alters GABAA receptor sub- unit mRNA levels in rat hippocam- pus. Brain Res. Mol. Brain Res. 34, 29–37. Owens, M. J., and Nemeroff, C. B. (1991). Physiology and pharmacol- ogy of corticotropin-releasing fac- tor. Pharmacol. Rev. 43, 425–473. Padberg, F., di Michele, F., Zwanzger, P., Romeo, E., Bernardi, G., Schule, C., Baghai, T. C., Ella, R., Pasini, A., and Rupprecht, R. (2002). Plasma concentrations of neuroac- tive steroids before and after repet- itive transcranial magnetic stimu- lation (rTMS) in major depres- sion. Neuropsychopharmacology 27, 874–878. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapere, J. J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M. R., and Gavish, M. (2006). Translocator protein (18kDa): new nomenclature for the peripheral- type benzodiazepine receptor based on its structure and molecular func- tion. Trends Pharmacol. Sci. 27, 402–409. Patchev, V. K., Hassan, A. H., Hols- boer, D. F., and Almeida, O. F. (1996). The neurosteroid tetrahy- droprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcrip- tion in the rat hypothalamus. Neuropsychopharmacology 15, 533–540. Patchev, V. K., Montkowski, A., Rouskova, D., Koranyi, L., Holsboer, F., and Almeida, O. F. (1997). Neonatal treatment of rats with the neuroactive steroid tetrahy- drodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J. Clin. Invest. 99, 962–966. December 2011 | Volume 5 | Article 131 | 17